These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 37090051)
41. Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies. Mahler M; Malyavantham K; Seaman A; Bentow C; Anunciacion-Llunell A; Sanz-Martínez MT; Viñas-Gimenez L; Selva-O'Callaghan A Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943483 [TBL] [Abstract][Full Text] [Related]
42. Diagnosis and classification of idiopathic inflammatory myopathies. Lundberg IE; Miller FW; Tjärnlund A; Bottai M J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359 [TBL] [Abstract][Full Text] [Related]
46. [Clinical and pathological characteristics of immune mediated necrotizing myopathy]. Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492 [TBL] [Abstract][Full Text] [Related]
47. Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity. Zhao L; Su K; Liu T; Sun D; Jiang Z Clin Rheumatol; 2021 Mar; 40(3):1009-1016. PubMed ID: 32676923 [TBL] [Abstract][Full Text] [Related]
48. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies. Ueki M; Kobayashi I; Takezaki S; Tozawa Y; Okura Y; Yamada M; Kuwana M; Ariga T Mod Rheumatol; 2019 Mar; 29(2):351-356. PubMed ID: 29532710 [TBL] [Abstract][Full Text] [Related]
49. Geographical Latitude Remains as an Important Factor for the Prevalence of Some Myositis Autoantibodies: A Systematic Review. Aguilar-Vazquez A; Chavarria-Avila E; Pizano-Martinez O; Ramos-Hernandez A; Andrade-Ortega L; Rubio-Arellano ED; Vazquez-Del Mercado M Front Immunol; 2021; 12():672008. PubMed ID: 33968081 [TBL] [Abstract][Full Text] [Related]
50. High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis. Nakajima A; Yoshino K; Soejima M; Kawaguchi Y; Satoh T; Kuwana M; Yamanaka H Rheumatol Int; 2012 Jul; 32(7):2057-61. PubMed ID: 21479881 [TBL] [Abstract][Full Text] [Related]
52. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions. Hirakata M Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673 [TBL] [Abstract][Full Text] [Related]
53. Anti-mitochondrial antibodies in Indian patients with idiopathic inflammatory myopathies. Gaur PS; R N; Anuja AK; Singh MK; Rai MK; Muhammed R; Sahu AK; Agarwal V; Gupta L Int J Rheum Dis; 2022 Jun; 25(6):659-668. PubMed ID: 35384316 [TBL] [Abstract][Full Text] [Related]
54. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379 [TBL] [Abstract][Full Text] [Related]
55. Diagnostic performance of a commercial immunoblot assay for myositis antibody testing. Bundell C; Rojana-Udomsart A; Mastaglia F; Hollingsworth P; McLean-Tooke A Pathology; 2016 Jun; 48(4):363-6. PubMed ID: 27114370 [TBL] [Abstract][Full Text] [Related]
56. Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry. Zhang L; Zhu H; Yang P; Duan X; Wei W; Wu Z; Fang Y; Li Q; Liu S; Shi X; Li H; Wu C; Zhou S; Leng X; Zhao J; Xu D; Wu Q; Tian X; Li M; Zhao Y; Wang Q; Zeng X; Clin Rheumatol; 2021 Nov; 40(11):4597-4608. PubMed ID: 34184155 [TBL] [Abstract][Full Text] [Related]
57. Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review. Tiniakou E; Mammen AL Clin Rev Allergy Immunol; 2017 Feb; 52(1):20-33. PubMed ID: 26429706 [TBL] [Abstract][Full Text] [Related]
58. The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review. Teel A; Lu J; Park J; Singh N; Basharat P Semin Arthritis Rheum; 2022 Dec; 57():152088. PubMed ID: 36116345 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464 [TBL] [Abstract][Full Text] [Related]
60. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Hausmanowa-Petrusewicz I; Kowalska-Oledzka E; Miller FW; Jarzabek-Chorzelska M; Targoff IN; Blaszczyk-Kostanecka M; Jablonska S Arthritis Rheum; 1997 Jul; 40(7):1257-66. PubMed ID: 9214426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]